PeptidePedia The community reference

Missed dose (revision 1)

Old revision·02:11, 26 Sep 2024·FootnoteFyfe

This is an old revision of this page, as it stood at 02:11, 26 Sep 2024, saved by FootnoteFyfe with the summary create article — preparation and handling stub. It may differ substantially from the current revision, and any error it contains may since have been corrected.
Missed dose
Governing quantityHalf-life relative to dosing interval
Weekly agentsLong half-life; concentration falls slowly
Daily agentsSteady state re-established within days
Topic infobox · conventions

A missed dose is a scheduled administration that is not taken. How much it matters depends almost entirely on the ratio between the drug's half-life and its dosing interval: a long half-life relative to the interval means concentrations fall slowly and a single omission changes exposure little.[1]

For a weekly agent with a half-life of several days, the concentration at the end of a normal dosing interval has fallen to a substantial fraction of its peak, and a missed week extends that decline rather than producing a sudden loss of exposure. For a daily agent with a half-life of hours, a missed day is a larger proportional change but is corrected within a day or two of resuming.[2]

References

  1. ^ Drucker DJ. "Mechanisms of action and therapeutic application of glucagon-like peptide-1." Cell Metabolism 27(4):740–756 (2018). PMID 29617641.
  2. ^ Knudsen LB, Lau J. "The discovery and development of liraglutide and semaglutide." Frontiers in Endocrinology 10:155 (2019). PMID 31031702.